CT imaging of myocardial scars with collagen-targeting gold nanoparticles

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 9, Issue 7, 2013, Pages 1067-1076

  Danila, Delia ^a   Johnson, Evan ^a   Kee, Patrick ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

CT imaging; Gold nanoparticles; Molecular imaging; Myocardial scars

Indexed keywords

COMPUTED TOMOGRAPHIC; CONTRAST ENHANCEMENT; CT IMAGING; GOLD NANOPARTICLES; LEFT ANTERIOR DESCENDING; MYOCARDIAL FUNCTION; MYOCARDIAL SCARS; VASCULAR STRUCTURES;

COLLAGEN; GOLD; MAMMALS; METAL NANOPARTICLES; MOLECULAR IMAGING;

COMPUTERIZED TOMOGRAPHY;

ADHESIN; COLLAGEN; CONTRAST MEDIUM; GOLD NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; FLOCCULATION; HEART MUSCLE REPERFUSION; HISTOLOGY; IMAGE ANALYSIS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MOUSE; MYOCARDIAL DISEASE; MYOCARDIAL SCAR; NONHUMAN; SCAR FORMATION;

MUS; RODENTIA;

CT IMAGING; GOLD NANOPARTICLES; MOLECULAR IMAGING; MYOCARDIAL SCARS;

ANIMALS; CICATRIX; COLLAGEN; FEMALE; GOLD; LIGHT; METAL NANOPARTICLES; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; POLYETHYLENE GLYCOLS; PROTEIN BINDING; SCATTERING, RADIATION; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84884281165     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.03.009     Document Type: Article

References (62)

1. Valensi P., Lorgis L., Cotlin Y. Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature. Arch Cardiovasc Dis 2011, 104(3):178-188.
2. Al-Obaidi M.K., Etherington P.J., Barron D.J., Winlove C.P., Pepper J.R. Myocardial tissue oxygen supply and utilization during coronary artery bypass surgery: evidence of microvascular no-reflow. Clin Sci (Lond) 2000, 98(3):321-328.
3. Häggblad E., Lindbergh T., Karlsson M.G., Casimir-Ahn H., Salerud E.G., Strömberg T. Myocardial tissue oxygenation estimated with calibrated diffuse reflectance spectroscopy during coronary artery bypass grafting. J Biomed Opt 2008, 13(5):054030.
4. Rodríguez-Granillo G.A., Rosales M.A., Degrossi E., Rodriguez A.E. Signal density of left ventricular myocardial segments and impact of beam hardening artifact: implications for myocardial perfusion assessment by multidetector CT coronary angiography. Int J Cardiovasc Imaging 2010, 26(3):345-354.
5. Crossett M.P., Schneider-Kolsky M., Troupis J.J. Normal perfusion of the left ventricular myocardium using 320 MDCT. Cardiovasc Comput Tomogr 2011, 5(6):406-411.
6. Hyafil F., Cornily J.C., Feig J.E., Gordon R., Vucic E., Amirbekian V., et al. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat. Med 2007, 13(5):636-641.
7. Hyafil F., Cornily J.-C., Rudd J.H.F., Machac J., Feldman L.J., Fayad Z.A. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology. J Nucl Med 2009, 50(6):959-965.
8. Bhavane R., Badea C., Ghaghada K.B., Clark D., Vela D., Moturu A., et al. Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent. Circ Cardiovasc Imaging 2013.
9. Yu S.B., Watson A.D. Metal-based x-ray contrast media. Chem Rev 1999, 99(9):2353-2378.
10. Hainfeld J.F., Slatkin D.N., Focella T.M., Smilowitz H.M. Gold nanoparticles: a new x-ray contrast agent. Br J Radiol 2006, 79:248-253.
11. Raynal I., Prigent P., Peyramaure S., Najid A., Rebuzzi C., Corot C. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 2004, 39:56-63.
12. Rogers W.J., Basu P. Factors regulating macrophage endocytosis of nanoparticles: implications for targeted magnetic resonance plaque imaging. Atherosclerosis 2005, 178:67-73.
13. Woodle M.C., Engbers C.M., Zalipsky S. New amphipatic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes. Bioconjugate Chem. 1994, 5:493-496.
14. Ballou B., Lagerholm B.C., Ernst L.A., Bruchez M.P., Waggoner A.S. Noninvasive imaging of quantum dots in mice. Bioconjugate Chem 2004, 15:79-86.
15. Kohler N., Fryxell G.E., Zhang M. A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. J Am Chem Soc 2004, 126:7206-7211.
16. Rockwell S.C., Kallman R.F., Fajardo L.F. Characteristics of a serially transplanted mouse mammary tumor and its tissue- culture-adapted derivative. J Natl Cancer Inst 1972, 49:735-749.
17. Herrwerth S., Rosendahl T., Feng C., Fick J., Eck W., Himmelhaus M., et al. Covalent coupling of antibodies to self-assembled monolayers of carboxy-functionalized poly(ethylene glycol): protein resistance and specific binding of biomolecules. Langmuir 2003, 19:1880-1887.
18. Otsuka H., Akiyama Y., Nagasaki Y., Kataoka K. Quantitative and reversible lectin-induced association of gold nanoparticles modified with alpha-lactosyl-omega-mercapto-poly(ethylene glycol). J Am Chem Soc 2001, 123:8226-8230.
19. Otsuka H., Nagasaki Y., Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Delivery Rev 2003, 55:403-419.
20. Garcia B., Salome M., Lemelle L., Bridot J.-L., Gillet P., Perriat P., et al. Sulfur K-edge XANES study of dihydrolipoic acid capped gold nanoparticles: dihydrolipoic acid is bound by both sulfur ends. Chem. Commun 2005, 369-371.
21. Pierrat S., Zins I., Breivogel A., Soennichsen C. Self-assembly of small gold colloids with functionalized gold nanorods. Nano Lett 2007, 7:259-263.
22. Shenoy D., Fu W., Li J., Crasto C., Jones G., DiMarzio C., et al. Surface functionalization of gold nanoparticles using hetero-bifunctional poly(ethylene glycol) spacer for intracellular tracking and delivery. Int J Nanomedicine 2006, 1:51-57.
23. Sperling R.A., Pellegrino T., Li J.K., Chang W.H., Parak W.J. Electrophoretic separation of nanoparticles with a discrete number of functional groups. Adv Funct Mater 2006, 16:943-948.
24. Sun C., Sze R., Zhang M. Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. J. Biomed. Mater. Res., Part A 2006, 78A:550-557.
25. Abad J.M., Mertens S.F.L., Pita M., Fernandez V.M., Schiffrin D.J. Functionalization of thioctic acid-capped gold nanoparticles for specific immobilization of histidine-tagged proteins. J Am Chem Soc 2005, 127:5689-5694.
26. Reuveni T., Motiei M., Romman Z., Popovtzer A., Popovtzer R. Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study. IJN 2011, 6:2859-2864.
27. Chattopadhyay N., Cai Z., Pignol J.-P., Keller B., Lechtman E., Bendayan R., et al. Design and characterization of HER-2-targeted gold nanoparticles for enhanced x-radiation treatment of locally advanced breast cancer. Mol Pharm 2010, 7:2194-2206.
28. Rabin O., Manuel Perez J., Grimm J., Wojtkiewicz G., Weissleder R. An x-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater 2006, 5(2):118-122.
29. Torres A.S., Bonitatibus P.J., Colborn R.E., Goddard G.D., FitzGerald P.F., Lee B.D., et al. Biological performance of a size-fractionated core-shell tantalum oxide nanoparticle x-ray contrast agent. Invest Radiol 2012, 47(10):578-587.
30. Oh M.H., Lee N., Kim H., Park S.P., Piao Y., Lee J., et al. Large-scale synthesis of bioinert tantalum oxide nanoparticles for x-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping. J Am Chem Soc 2011, 133(14):5508-5515.
31. Patti J.M., Bremell T., Krajewska-Pietrasik D., Abdelnour A., Tarkowski A., Ryden C., et al. The Staphylococcus aureus collagen adhesion is a virulence determinant in experimental septic arthritis. Infect Immun 1994, 62(1):152-161.
32. Xu Y., Rivas J.M., Brown E.L., Liang X., Hook M. Virulence potential of the staphylococcal adhesion CNA in experimental arthritis is determined by its affinity for collagen. J Infect Dis 2004, 189(12):1323-1333.
33. Krahn K.N., Bouten C.V., van Tujil S., van Zandvoort M.A., Merkx M. Fluorescently labeled collagen binding proteins allow specific visualization of collagen in tissues and live cell culture. Anal Biochem 2006, 350(2):177-185.
34. Helm P.A., Caravan P., French B.A., Jacques V., Shen L., Xu Y., et al. Postinfarction myocardial scarring in mice: molecular MRI imaging with use of a collagen-targeting contrast agent. Radiology 2008, 247(3):788-796.
35. Cai Q.Y., Kim S.H., Choi K.S., Kim S.Y., Byun S.J., Kim K.W., et al. Colloidal gold nanoparticles as a blood-pool contrast agent for x-ray computed tomography in mice. Invest Radiol 2007, 42:797-806.
36. Yetkin E., Senen K., Ileri M., Atak R., Tandogan I., Yetkin O., et al. Comparison of low-dose dobutamine stress echocardiography and echocardiography during glucose-insulin-potassium infusion for detection of myocardial viability after anterior myocardial infarction. Coronary Artery Dis 2002, 13(3):145-149.
37. Parsai C., Baltabaeva A., Anderson L., Chaparro M., Bijnens B., Sutherland G.R. Low-dose dobutamine stress echo to quantify the dregree of remodeling after cardiac resynchronization therapy. Eur Heart J 2009, 30:950-958.
38. Kim R.J., Shah D.J. Fundamental concepts in myocardial viability assessment revisited: when knowing how much is "alive" is not enough. Heart 2004, 90(2):137-140.
39. Nathan M., Ying L.C., Pierre C., David B., Joao L. Assessment of myocardial fibrosis with cardiac magnetic resonance. J Am Coll Cardiol 2009, 54:242-249.
40. Grover-McKay M. Detection of myocardial viability and infarction using cardiac MRI. Applied Radiology 2002, 15-16.
41. Kim R.J., Chen E.L., Lima J.A.C., Judd R.M. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996, 94:3318-3326.
42. Assomull R.G., Prasad S.K., Lyne J. Cardiovascular magnetic resonance, fibrosis and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006, 48:1977-1985.
43. Mahrholdt H., Wagner A., Holly T.A. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation 2002, 106:2322-2327.
44. Sosnovik D.E., Wang R., Dai G., Reese T.G., Wedeen V.J. Diffusion MR tractography of the heart. J Cardiovasc Magnc Reson 2009, 11:47.
45. van Jaarsveld C.H., Jahangier Z.N., Jacobs J.W., Blaauw A.A., van Albada-Kuipers G.A., ter Borg E.J., et al. Rheumatology (Oxford) 2000, 39(12):1374.
46. Dobrovolskaia M.A., Patri A.K., Zheng J., Clogston J.D., Ayub N., Aggarwal P., et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine: Nanotechnol Biol Med 2009, 5(2):106-117.
47. Connor E.E., Mwamuka J., Gole A., Murphy C.J., Wyatt M.D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005, 1:325-327.
48. Shukla R., Bansal V., Chaudhary M., Basu A., Bhonde R.R., Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 2005, 21:10644-10654.
49. Villiers C.L., Freitas H., Couderc R., Villiers M.B., Marche P.N. Analysis of the toxicity of gold nanoparticles on the immune system: effect on dendritic cell functions. J Nanopart Res. 2009, 12:55-60.
50. Goodman C.M., McCusker C.D., Yilmaz T., Rotello V.M. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 2004, 15:897-900.
51. Turner M., Golovko V.B., Vaughan O.P.H., et al. Selective oxidation with dioxygen by gold nanoparticle catalysts derived from 55-atom clusters. Nature 2008, 454:U31-U981.
52. Chithrani B.D., Ghazani A.A., Chan W.C.W. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006, 6662-6668.
53. Sonavane G., Tomoda K., Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces 2008, 66(2):274-280.
54. Hainfield J.F., Slatkin D.N., Focella T.M., Smilowitz H.M. Gold nanoparticles: a new x-ray contrast agent. Br J Radiol 2006, 79:248-253.
55. Boote, et al. Gold nanoparticle contrast in a phantom and juvenile swine: models for molecular imaging of human organs using x-ray computed tomography. Acad Radiol 2010, 17(4):410-417.
56. Alexandridis P. Gold nanoparticle synthesis, morphology control, and stabilization facilitated by functional polymers. Chem Eng Technol 2011, 34(1):15-28.
57. Kimling J., Maier M., Okenve B., Kotaidis V., Ballot H., Plech A., et al. Method for gold nanoparticle synthesis revisited. J Phys Chem B 2006, 110(32):15700-15707.
58. Liu X., Atwater M., Wang J., Huo Q. Extinction coefficient of gold nanoparticles with different sizes and different capping ligands. Colloids Surf B Biointerfaces 2007, 58(1):3-7.
59. Luo Y. One-step preparation of gold nanoparticles with different size distribution. Mater Lett 2007, 61:1039-1041.
60. Rostro-Kohanloo B.C., Bickford L.R., Payne C.M., Day E.S., Anderson L.J.E., Zhong M., et al. The stabilization and targeting of surfactant-synthesized gold nanorods. Nanotechnology 2009, 20(43):19801751.
61. Lowery A.R., Gobin A.M., Day E.S., Halas N.J., West J.L. Immunonanoshells for targeted photothermal ablation of tumor cells. Int J Nanomedicine 2006, 1(2):149-154.
62. Xie H., Tkachenko A.G., Glomm W.R., Ryan J.A., Brennaman M.K., Papanikolas J.M., et al. Critical flocculation concentrations, binding isotherms, and ligand exchange properties of peptide-modifies gold nanoparticles studied by UV-Visible, fluorescence, and time-correlated single photon counting spectroscopies. Anal Chem 2003, 75:5797-5805.